Towards a Structural View of Drug Binding to hERG K⁺ Channels

Area of Science:

• Cardiovascular Science
• Molecular Biology
• Pharmacology

Background:

• The human ether-a-go-go-related gene (hERG) K+ channel is critical for cardiac electrical activity.
• Mutations in hERG cause congenital long-QT syndrome, increasing the risk of fatal arrhythmias.
• hERG channels are a common target for drug-induced cardiotoxicity, leading to acquired long-QT syndrome.

Purpose of the Study:

• To elucidate the structural basis of hERG channel function.
• To understand the molecular mechanisms underlying drug interactions with hERG channels.
• To provide insights into the promiscuity of drug binding to hERG.

Main Methods:

• Single-particle cryo-electron microscopy (cryo-EM) was employed to determine the near-atomic resolution structure of the hERG K+ channel.
• Structural analysis was used to infer functional mechanisms and drug binding sites.

Main Results:

• Near-atomic resolution structures of the hERG K+ channel were determined.
• The structures provide unprecedented insights into the channel's gating mechanisms and architecture.
• The findings offer a structural basis for understanding the broad range of drugs that block hERG channels.

Conclusions:

• The determined hERG channel structures offer a significant advancement in understanding its physiological role and pathological mutations.
• These structural insights are crucial for predicting and mitigating drug-induced hERG channel block and associated cardiac risks.
• Future research can leverage these structures to design safer drugs with reduced cardiotoxic potential.